Dried Blood Spot Sampling for Hepatitis B Virus Serology and Molecular Testing

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Mohamed, Sofiane ^a,f   Raimondo, Audrey ^b   Pénaranda, Guillaume ^a   Camus, Claire ^a   Ouzan, Denis ^c   Ravet, Sophie ^b   Bourlière, Marc ^d   Khiri, Hacène ^a   Dukan, Patrick ^e   Olive, Daniel ^f   Halfon, Philippe ^a,e  

^a Laboratoire Alphabio   (France)

^b CDL Pharma   (France)

^c INSTITUT ARNAULT TZANCK   (France)

^d HÔPITAL SAINT JOSEPH   (France)

^e Hospital Ambroise Pare   (France)

^f INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ANTIGEN DETECTION; ARTICLE; BIOASSAY; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRIED BLOOD SPOT TESTING; FEASIBILITY STUDY; GENE IDENTIFICATION; GENE MUTATION; GENOTYPING TECHNIQUE; HEPATITIS B VIRUS; HUMAN; IN VITRO STUDY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; STRUCTURAL GENE; VIRUS DIAGNOSIS; VIRUS LOAD;

BLOOD SPECIMEN COLLECTION; DNA, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS;

HEPATITIS B VIRUS;

EID: 84876167307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061077     Document Type: Article

References (38)

1. Fattovich G, (2003) Natural history and prognosis of hepatitis B. Semin Liver Dis. 23: 47-58.
2. McMahon BJ, (2004) The natural history of chronic hepatitis B virus infection. Semin Liver Dis 24Suppl 1: 17-21.
3. Hadziyannis SJ, Papatheodoridis GV, (2006) Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis 26: 130-141.
4. Ganem D, Prince AM, (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350: 1118-1129.
5. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS, (2007) Management of hepatitis B: summary of a clinical research workshop. Hepatology 45: 1056-1075.
6. Liaw YF, (2005) Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma. Semin Liver Dis 25Suppl 1: 40-47.
7. Lok AS, McMahon BJ, (2007) Chronic hepatitis B. Hepatology. 45: 507-539.
8. Kassak K, Mahfoud Z, Kreidieh K, Shamra S, Afifi R, et al. (2011) Hepatitis B virus and hepatitis C virus infections among female sex workers and men who have sex with men in Lebanon: prevalence, risk behaviour and immune status. Sex Health 8: 229-233.
9. Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, et al. (2002) Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 185: 713-719.
10. Whelan J, Sonder G, Heuker J, van den Hoek A, (2012) Incidence of acute hepatitis B in different ethnic groups in a low-endemic country, 1992-2009: Increased risk in second generation migrants. Vaccine 30: 5651-5655.
11. Halfon P, Ouzan D, Khiri H, Penaranda G, Castellani P, et al. (2012) Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spots. PLoS One 7: e33000.
12. Chevaliez S, Rodriguez C, Pawlotsky JM (2012) New virologic tools for management of chronic hepatitis B and C. Gastroenterology 142: 1303-1313 e1301.
13. Beck IA, Drennan KD, Melvin AJ, Mohan KM, Herz AM, et al. (2001) Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J Clin Microbiol 39: 29-33.
14. Chanbancherd P, Brown AE, Trichavaroj R, Tienamporn P, Puthakird P, et al. (1999) Application of dried blood spot specimens for serologic subtyping of human immunodeficiency virus type 1 in Thailand. J Clin Microbiol 37: 804-806.
15. Gupta BP, Jayasuryan N, Jameel S, (1992) Direct detection of hepatitis B virus from dried blood spots by polymerase chain reaction amplification. J Clin Microbiol 30: 1913-1916.
16. Tappin DM, Greer K, Cameron S, Kennedy R, Brown AJ, et al. (1998) Maternal antibody to hepatitis B core antigen detected in dried neonatal blood spot samples. Epidemiol Infect 121: 387-390.
17. Jardi R, Rodriguez-Frias F, Buti M, Schaper M, Valdes A, et al. (2004) Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA. Hepatology 40: 133-139.
18. Mendy M, Kirk GD, van der Sande M, Jeng-Barry A, Lesi OA, et al. (2005) Hepatitis B surface antigenaemia and alpha-foetoprotein detection from dried blood spots: applications to field-based studies and to clinical care in hepatitis B virus endemic areas. J Viral Hepat 12: 642-647.
19. Komas NP, Bai-Sepou S, Manirakiza A, Leal J, Bere A, et al. (2010) The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African Republic. BMC Infect Dis 10: 226.
20. Bland JM, Altman DG, (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
21. Brugal MT, Pulido J, Toro C, de la Fuente L, Bravo MJ, et al. (2009) Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain. Eur Addict Res 15: 171-178.
22. Lukacs Z, Dietrich A, Ganschow R, Kohlschutter A, Kruithof R, (2005) Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots-a feasibility study using a multi-analyte immunoassay. Clin Chem Lab Med 43: 141-145.
23. Vallejo F, Toro C, de la Fuente L, Brugal MT, Barrio G, et al. (2008) Hepatitis B vaccination: an unmet challenge in the era of harm reduction programs. J Subst Abuse Treat 34: 398-406.
24. Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S, (2010) Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon. Virol J 7: 96.
25. Forbi JC, Obagu JO, Gyar SD, Pam CR, Pennap GR, et al. (2010) Application of dried blood spot in the sero-diagnosis of hepatitis B infection (HBV) in an HBV hyper-endemic nation. Ann Afr Med 9: 44-45.
26. Villar LM, de Oliveira JC, Cruz HM, Yoshida CF, Lampe E, et al. (2011) Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers. J Med Virol 83: 1522-1529.
27. European Association For The Study Of The Liver, (2012) EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol 57: 167-185.
28. Bertagnolio S, Parkin NT, Jordan M, Brooks J, Garcia-Lerma JG, (2010) Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev 12: 195-208.
29. Neumaier M, Braun A, Wagener C, (1998) Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques. Clin Chem 44: 12-26.
30. Mei JV, Alexander JR, Adam BW, Hannon WH, (2001) Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 131: 1631S-1636S.
31. Therrell BL, Hannon WH, Pass KA, Lorey F, Brokopp C, et al. (1996) Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med 57: 116-124.
32. Tuaillon E, Mondain AM, Meroueh F, Ottomani L, Picot MC, et al. (2010) Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology 51: 752-758.
33. Ott JJ, Stevens GA, Groeger J, Wiersma ST, (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30: 2212-2219.
34. Viljoen J, Gampini S, Danaviah S, Valea D, Pillay S, et al. (2010) Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso. J Acquir Immune Defic Syndr 55: 290-298.
35. Ibrahim SA, Abdallah A, Saleh EA, Osterhaus AD, De Swart RL, (2006) Measles virus-specific antibody levels in Sudanese infants: a prospective study using filter-paper blood samples. Epidemiol Infect 134: 79-85.
36. Snijdewind IJ, van Kampen JJ, Fraaij PL, van der Ende ME, Osterhaus AD, et al. (2012) Current and future applications of dried blood spots in viral disease management. Antiviral Res 93: 309-321.
37. Snow-Lampart A, Chappell B, Curtis M, Zhu Y, Myrick F, et al. (2011) No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus. Hepatology 53: 763-773.
38. Lampertico P, Liaw YF, (2012) New perspectives in the therapy of chronic hepatitis B. Gut. 61Suppl 1: i18-24.